User menu

Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study.

Bibliographic reference Gulmez, Sinem Ezgi ; Larrey, Dominique ; Pageaux, Georges-Philippe ; Lignot, Severine ; Lassalle, Régis ; et. al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study.. In: Drug Safety, Vol. 36, no.2, p. 135-144 (2013)
Permanent URL
  1. Reuben Adrian, Koch David G., Lee William M., Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study, 10.1002/hep.23937
  2. Keisu M., Andersson T. B., Drug-Induced Liver Injury in Humans: The Case of Ximelagatran, Handbook of Experimental Pharmacology (2010) ISBN:9783642006623 p.407-418, 10.1007/978-3-642-00663-0_13
  3. Lee William M., Drug-Induced Hepatotoxicity, 10.1056/nejmra021844
  4. Danan G., Trunet P., Bernuau J., Degott C., Babany G., Pessayre D., Rueff B., Benhamou J.P., Pirprofen-induced fulminant hepatitis, 10.1016/0016-5085(85)90765-6
  5. Bessone Fernando, Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?, 10.3748/wjg.v16.i45.5651
  6. Traversa G., Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs, 10.1136/bmj.327.7405.18
  7. Lee Chang-Hsing, Wang Jung-Der, Chen Pau-Chung, Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs, 10.1002/pds.1966
  8. Théophile Hélène, Laporte Joan-Ramon, Moore Nicholas, Martin Karin-Latry, Bégaud Bernard, The Case-Population Study Design : An Analysis of its Application in Pharmacovigilance, 10.2165/11592140-000000000-00000
  9. Gülmez Sinem Ezgi, Lignot-Maleyran Séverine, de Vries Corinne S., Sturkenboom Miriam, Micon Sophie, Hamoud Fatima, Blin Patrick, Moore Nicholas, Administrative complexities for a European observational study despite directives harmonising requirements : EUROPEAN HARMONISATION, 10.1002/pds.3204
  10. O'Grady J G, Acute liver failure, 10.1136/pgmj.2004.026005
  11. O'Grady John G., Alexander Graeme J.M., Hayllar Karen M., Williams Roger, Early indicators of prognosis in fulminant hepatic failure, 10.1016/0016-5085(89)90081-4
  12. Bernuau Jacques, Goudeau Alain, Poynard Thierry, Dubois Frederic, Lesage Gerard, Yvonnet Bernard, Degott Claude, Bezeaud Annie, Rueff Bernard, Benhamou Jean-Pierre, Multivariate analysis of prognostic factors in fulminant hepatitis B, 10.1002/hep.1840060417
  13. Criteria of drug-induced liver disorders, 10.1016/0168-8278(90)90124-a
  14. Benichou Christian, Danan Gaby, Flahault Antoine, Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge, 10.1016/0895-4356(93)90102-7
  15. Danan Gaby, Benichou Christian, Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries, 10.1016/0895-4356(93)90101-6
  16. Danan G, Benichou C, Begaud B, Biour M, Couzigou P, Evreux JC, et al. Criteria of imputation of acute hepatitis to a drug: results of consensus meetings [in French]. Gastroenterol Clin Biol. 1987;11(8–9):581–5.
  17. Guidelines for ATC classification and DDD assignment. 4th ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2001.
  18. Fourrier-Reglat A, Cuong HM, Lassalle R, Depont F, Robinson P, Droz-Perroteau C, et al. Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort. Pharmacoepidemiol Drug Saf. 2010;19(5):474–81.
  19. Fourrier-Réglat A, Lacoin L, Pariente A, Lassalle R, Robinson P, Droz-Perroteau C, Bégaud B, Blin P, Moore N D, When Patients Report Diseases That Prescribers Seem Unaware of: Discordance Between Patient and Physician Reporting of Risk-Related Previous History in NSAID Users From the CADEUS Study, 10.1038/clpt.2010.166
  20. Moore N, Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects, 10.1067/mcp.2001.116147
  21. Depont F., Fourrier A., Merlière Y., Droz C., Amouretti M., Bégaud B., Bénichou J., Moride Y., Velo G. P., Sturkenboom M., Blin P., Moore N., , Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study, 10.1002/pds.1388
  22. Depont F., Fourrier A., Merlière Y., Droz C., Amouretti M., Bégaud B., Bénichou J., Moride Y., Blin P., Moore N., , The CADEUS study: methods and logistics, 10.1002/pds.1348
  23. Chalasani Naga, Björnsson Einar, Risk Factors for Idiosyncratic Drug-Induced Liver Injury, 10.1053/j.gastro.2010.04.001
  24. Maddur Haripriya, Chalasani Naga, Idiosyncratic Drug-Induced Liver Injury: A Clinical Update, 10.1007/s11894-010-0154-8
  25. Aithal Guruprasad P., Day Christopher P., Nonsteroidal Anti-Inflammatory Drug–Induced Hepatotoxicity, 10.1016/j.cld.2007.06.004
  26. Ponsoda X., Bort R., Jover R., Gómez-lechón M.J., Castell J.V., Molecular mechanism of diclofenac hepatotoxicity: Association of cell injury with oxidative metabolism and decrease in ATP levels, 10.1016/0887-2333(95)00035-7
  27. Stirnimann G, Kessebohm K, Lauterburg B. Liver injury caused by drugs: an update. Swiss Med Wkly. 2010;140:w13080.
  28. Graham Garry G., Day Richard O., Graudins Andis, Mohamudally Anthoulla, FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable?, 10.1007/s10787-010-0036-6
  29. Guggenheimer James, Moore Paul A., The Therapeutic Applications of and Risks Associated With Acetaminophen Use, 10.14219/jada.archive.2011.0026
  30. Craig Darren G. N., Bates Caroline M., Davidson Janice S., Martin Kirsty G., Hayes Peter C., Simpson Kenneth J., Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity : Outcome following unintentional paracetamol overdose, 10.1111/j.1365-2125.2010.03819.x
  31. Sabaté Mònica, Ibáñez Luisa, Pérez Eulàlia, Vidal Xavier, Buti Maria, Xiol Xavier, Mas Antoni, Guarner Carlos, Forné Montserrat, Solà Ricard, Castellote José, Rigau Joaquim, Laporte Joan-Ramon, Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series, 10.1186/1471-230x-11-80
  32. Larson Anne M., Polson Julie, Fontana Robert J., Davern Timothy J., Lalani Ezmina, Hynan Linda S., Reisch Joan S., Schiødt Frank V., Ostapowicz George, Shakil A. Obaid, Lee William M., , Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study, 10.1002/hep.20948
  33. Andrade Raúl J, Lucena M.Isabel, García-Escaño M.Dolores, Camargo Raquel, Severe idiosyncratic acute hepatic injury caused by paracetamol, 10.1016/s0168-8278(98)80361-9
  34. Prescott Laurie F., Paracetamol : Past, Present, and Future, 10.1097/00045391-200007020-00011
  35. Prescott Laurie F., Therapeutic Misadventure with Paracetamol : Fact or Fiction?, 10.1097/00045391-200007020-00007
  36. Prescott Laurie F., Paracetamol, alcohol and the liver : Paracetamol, alcohol and the liver, 10.1046/j.1365-2125.2000.00167.x
  37. Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009;137(3):856–64, 864.e1.
  38. Weise Amy M, Liu Chin Y, Shields Anthony F, Fatal Liver Failure in a Patient on Acetaminophen Treated with Sunitinib Malate and Levothyroxine, 10.1345/aph.1l528